Minerva Neurosciences, Inc. SEC filings NERV
Minerva Neurosciences, Inc. has 645 filings in SEC EDGAR's recent list, going back to Feb 14, 2014. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | May 27, 2026 | — |
| S-3 | Shelf registration | Mar 11, 2026 | — |
| 424B3 | Prospectus | Jan 6, 2026 | — |
| S-8 | Employee stock plan registration | Dec 23, 2025 | — |
| S-3 | Shelf registration | Dec 23, 2025 | — |
| 424B3 | Prospectus | Aug 9, 2023 | — |
| S-3 | Shelf registration | Aug 4, 2023 | — |
| S-3 | Shelf registration | Sep 14, 2022 | — |
| S-8 | Employee stock plan registration | Aug 7, 2020 | — |
| S-3 | Shelf registration | Aug 10, 2018 | — |
| S-8 | Employee stock plan registration | Jun 15, 2018 | — |
| S-8 | Employee stock plan registration | Mar 12, 2018 | — |
| S-8 | Employee stock plan registration | Dec 29, 2017 | — |
| 424B5 | Prospectus supplement | Jun 29, 2017 | — |
| 424B5 | Prospectus supplement | Jun 27, 2017 | — |
| S-8 | Employee stock plan registration | Mar 13, 2017 | — |
| 424B5 | Prospectus supplement | Jun 14, 2016 | — |
| 424B5 | Prospectus supplement | Jun 13, 2016 | — |
| 424B3 | Prospectus | Apr 11, 2016 | — |
| S-8 | Employee stock plan registration | Mar 14, 2016 | — |
| 424B3 | Prospectus | Jan 22, 2016 | — |
| S-3 | Shelf registration | Jul 21, 2015 | — |
| POS AM | Filing | Jul 2, 2015 | — |
| 424B3 | Prospectus | Jun 18, 2015 | — |
| 424B3 | Prospectus | Jun 16, 2015 | — |
| 424B3 | Prospectus | May 19, 2015 | — |
| 424B4 | Prospectus | May 12, 2015 | — |
| S-1/A | Amended registration statement | May 7, 2015 | — |
| S-8 | Employee stock plan registration | Apr 30, 2015 | — |
| S-1 | Registration statement | Apr 30, 2015 | — |
| S-8 | Employee stock plan registration | Sep 15, 2014 | — |
| 424B4 | Prospectus | Jul 1, 2014 | — |
| FWP | Free writing prospectus | Jun 30, 2014 | — |
| S-1/A | Amended registration statement | Jun 30, 2014 | — |
| S-1/A | Amended registration statement | Jun 13, 2014 | — |
| S-1/A | Amended registration statement | Jun 10, 2014 | — |
| S-1 | Registration statement | Apr 9, 2014 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NERV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Burlington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1598646
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.